Stay updated on ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial
Sign up to get notified when there's something new on the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page.

Latest updates to the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page
- Check5 days agoChange DetectedThe page's revision/version label updated from v3.5.2 to v3.5.3. This reflects a small update to the page's metadata and does not change the visible study details.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded a Study Results entry and a Publications note indicating publications are provided voluntarily by the submitter. Removed General/IPD-sharing related entries.SummaryDifference0.5%

- Check41 days agoChange DetectedRevision notes updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded Revision: v3.4.2 and removed outdated notices (including the lapse in government funding notice and Revision: v3.4.1), reflecting minor site maintenance updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page.